The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options combined with the longevity and variable disease course of MS has led to the need to consider additional factors, such as safety, convenience, care during COVID-19, telehealth options, and the family planning process. Moreover, to ensure that patients receive optimal and timely therapy, early identification and diagnosis of those developing progressive disease is crucial. In this podcast series, experts in the field of MS review the current guidelines for the diagnosis and management of MS, and the roles of recent data of emerging therapies in the treatment algorithm.
MS Care During a Pandemic: COVID-19 and Telehealth, With Patricia K. Coyle, MD, FAAN, FANA; and Stephen Krieger, MD, FAAN
Expiration Date: 7/29/2022
Max Credits: 0.25
Current and Emerging Agents: Applying the Latest Evidence With Patricia K. Coyle, MD, FAAN, FANA; and Clyde E. Markowitz, MD
Expiration Date: 7/29/2022
Max Credits: 0.25
MS and the Family Planning Process: Opening Up the Discussion, With Patricia Melville and Patricia K. Coyle, MD, FAAN, FANA
Expiration Date: 7/29/2022
Max Credits: 0.25
Relapsing MS: Improving Patient Recognition With Patricia K. Coyle, MD, FAAN, FANA; and Stephen Krieger, MD, FAAN
Expiration Date: 7/29/2022
Max Credits: 0.25
Progressive MS: Selecting Optimal Treatments, With Patricia K. Coyle, MD, FAAN, FANA; and Clyde E. Markowitz, MD
Expiration Date: 7/29/2022
Max Credits: 0.25